CAMPTOSAR vs VERCYTE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. CAMPTOSAR and VERCYTE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAMPTOSAR	VERCYTE
Rating	60/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	IRINOTECAN HYDROCHLORIDE	PIPOBROMAN
Manufacturer	Pfizer	Abbott
Dosage forms	Injectable	Tablet
Drug class	Topoisomerase Inhibitor	—
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms	Leukemia, Polycythemia Vera

camptosar vercyte

Rating

60/100

72/100

Pharmacy pays

—

Type

Active ingredient

IRINOTECAN HYDROCHLORIDE

PIPOBROMAN

Manufacturer

Pfizer

Abbott

Dosage forms

Injectable

Tablet

Drug class

Topoisomerase Inhibitor

—

Boxed warning

None

Treats

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms

Leukemia, Polycythemia Vera

Frequently asked questions

Which is better-rated, Camptosar or Vercyte?

By our independent rating, Vercyte scores higher — 3.6 vs 3.0 out of 5 for Camptosar. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Camptosar and Vercyte?

Camptosar contains Irinotecan Hydrochloride, while Vercyte contains Pipobroman — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.